Search results
Results from the WOW.Com Content Network
The end results of reflux nephropathy can include high blood pressure, excessive protein loss in the urine, and eventually kidney failure. When reflux nephropathy is suspected as a cause of kidney disease, other conditions to consider include chronic pyelonephritis , obstructive uropathy , and analgesic overuse.
Acute kidney injury (AKI), previously called acute renal failure (ARF), [12] [13] is a rapidly progressive loss of renal function, [14] generally characterized by oliguria (decreased urine production, quantified as less than 400 mL per day in adults, [15] less than 0.5 mL/kg/h in children or less than 1 mL/kg/h in infants); and fluid and ...
1 if kidney damage present: 1: 2 G2 Mildly decreased: 60–89: 1 if kidney damage present: 1: 2 G3a Mildly to moderately decreased: 45–59: 1: 2: 3 G3b Moderately to severely decreased: 30–44: 2: 3: 3 G4 Severely decreased: 15–29: 3: 4+ 4+ G5 Kidney failure < 15: 4+ 4+ 4+ Numbers 1–4 indicates risk of progression as well as frequency of ...
Complications may include blood clots, infections, and high blood pressure. [1] Causes include a number of kidney diseases such as focal segmental glomerulosclerosis, membranous nephropathy, and minimal change disease. [1] [2] It may also occur as a complication of diabetes, lupus, or amyloidosis.
AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as kidney stones or blood clots, low blood pressure, or heart disease. It ...
[1] [3] Pyelonephritis affects about 1 to 2 per 1,000 women each year and just under 0.5 per 1,000 males. [5] [7] Young adult females are most often affected, followed by the very young and old. [2] With treatment, outcomes are generally good in young adults.
Kidney failure is known as the end-stage of kidney disease, where dialysis or a kidney transplant is the only treatment option. Chronic kidney disease is defined as prolonged kidney abnormalities (functional and/or structural in nature) that last for more than three months. [ 1 ]
The law provided $150 million for type 1 diabetes research in FY 2009. July 15, 2008—The Medicare Improvements for Patients and Providers Act of 2008 (P.L. 110–275) extended funding for the Special Statutory Funding Program for Type 1 Diabetes Research. The law provided $150 million per year for type 1 diabetes research in FY 2010 and FY 2011.